Methylsulfonylmethane: A Potential Dietary Supplement targeting sphingosine kinase 1 involved in Glioblastomamultiforme
Faizan Ahmad, Anik Karan, Richard L. Jayaraj
This study reports that methylsulfonylmethane (MSM) inhibits sphingosine kinase 1 (SphK1) and reduces glioma cell viability, suggesting it as a potential dietary supplement for GBM management.
bioRxiv · Sep 5, 2024 · PreprintPharmacology & Toxicology